PERK Inhibition Mitigates Restenosis and Thrombosis is a research paper published in JACC Basic to Translational Science (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1K25CA166178-01A1
Targeted Therapy of Neuroendocrine Cancers Via the Notch Signaling Pathway
National Institutes of Health
Grant: 5R01HL129785-03
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction
National Institutes of Health
Grant: 5R01HL143469-03
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery
National Institutes of Health
Grant: 5R01HL133665-03
BET Bromodomain proteins as Novel Epigenetic Targets for prevention of Intimal Hyperplasia after Vascular Surgery
Fields of Study
Sustainable Development Goals